1. Biomedical point-of-care microanalyzer for potentiometric determination of ammonium ion in plasma and whole blood
- Author
-
Antonio Calvo-López, Beatriz Rebollo-Calderon, Aida Ormazábal, Rafael Artuch, Javier Rosell-Ferrer, Julián Alonso-Chamarro, Mar Puyol, Universitat Politècnica de Catalunya. Departament d'Enginyeria Electrònica, and Universitat Politècnica de Catalunya. IEB - Instrumentació Electrònica i Biomèdica
- Subjects
Ion selective electrodes ,Monitoring ,Point-of-Care Systems ,Enginyeria biomèdica [Àrees temàtiques de la UPC] ,Microfluidics ,Cycloparaffins ,Biochemistry ,Blood ammonium ,Analytical Chemistry ,Biosensors ,Point-of-Care analyzer ,Ammonium Compounds ,Potentiometry ,Environmental Chemistry ,Hyperammonemia ,Humans ,Spectroscopy ,Enginyeria química::Química orgànica::Bioquímica [Àrees temàtiques de la UPC] - Abstract
Altres ajuts: acords transformatius de la UAB Some inborn errors of metabolism and other diseases can result in increasing blood ammonium (hyperammonemia episodes), which can cause serious neurological complications in patients or even death. Early diagnosis, follow up and treatment are essential to minimize irreversible damages in brain. Currently, adequate analytical instrumentation for the necessary ammonium bedside determination is not available in all health centers but only in clinical laboratories of reference hospitals. We therefore have developed a low cost and portable potentiometric Point-of-Care microanalyzer (POC) to address this problem. It consists of a cyclic olefin copolymer-based microanalyzer, the size of a credit card and working in continuous flow, which integrates microfluidics, a gas-diffusion module and a potentiometric detection system. The analytical features achieved are a linear range from 30 to 1000 μmol L NH , a detection limit of 18 μmol L NH and a required sample volume of 100 μL, which comply with the medical requirements. Plasma and blood samples are analyzed with no significant differences observed between ammonium concentrations obtained with both the proposed microanalyzer and the reference method. This demonstrates the value of the developed POC for bedside clinical applications.
- Published
- 2021